Alembic gets USFDA nod for generic pain-relief medication

The company has received final approval from the US Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Ketorolac Tromethamine Injection In multiple strengths, the drug maker said in a statement.

from Moneycontrol Business News https://ift.tt/hiBnu8T